期刊文献+

携带人肝细胞生长因子基因的重组腺病毒对大鼠局灶性脑缺血治疗的实验研究 被引量:5

Therapeutic effect of adenovirus-mediated hepatocyte growth factor gene transfer on transient focal cerebral ischemia in rats
原文传递
导出
摘要 目的 :观察携带人肝细胞生长因子基因的重组腺病毒 (Ad_HGF)对大鼠局灶性脑缺血的治疗作用。方法 :建立大鼠局灶性脑缺血动物模型。携带人肝细胞生长因子基因的穿梭质粒与携带复制缺陷的人血清 5型腺病毒基因组的质粒在 2 93细胞进行同源重组 ,构建Ad_HGF。携带绿色荧光蛋白基因的重组腺病毒 (Ad_GFP)载体注射到局灶性缺血大鼠的缺血侧侧脑室 ,观察其在脑内的表达部位和持续时间。动物给药治疗后 3d ,取大脑 ,平均切成 4片 ,用TTC染色评价Ad_HGF对缺血的治疗效果。结果 :Ad_GFP仅在大鼠双侧侧脑室壁及脑室内的脉络膜细胞表达 ,表达持续两周左右 ;Ad_HGF治疗组动物大脑缺血区明显小于非治疗组动物 (P <0 .0 5 )。结论 :Ad_HGF能显著缩小大鼠局灶性脑缺血区。 Objective:To investigate the therapeutic effect of adenovirus-mediated expression of hepatocyte growth factor gene(HGF) on transient focal cerebral ischemia in a rat modal.Methods:A rat model of transient focal cerebral ischemia due to middle cerebral artery(MCA) occlusion was adopted.Recombinant adenovirus carrying HGF gene(Ad-HGF) was constructed in 293 cells.After intraventricular injection of adenovirus carrying green fluorescent protein(Ad-GFP),a reporter gene,the expression was observed.After single cerebral ventricular injection of Ad-HGF into rats of the treatment group immediately after surgery,its therapeutic effect on transient focal cerebral ischemia was evaluated by TTC staining of the frontally sectioned brain removed on day 3.Result:GFP expression was visualized only in the ependymal cells and cells surrounding ventricular region in both hemispheres from day 1 to day 14.In rats of the treatment group,the infarct volume was significantly smaller after application of HGF compared with control rats without injection of Ad-HGF(P<0.05).Conclusion:Ad-HGF reduced the infarct areas after transient focal cerebral ischemia in rats.
出处 《军事医学科学院院刊》 CSCD 北大核心 2003年第6期406-408,共3页 Bulletin of the Academy of Military Medical Sciences
基金 国家"8 63"高技术发展计划资助项目(No .2 0 0 1AA2 170 61)
关键词 肝细胞生长因子 腺病毒科 重组腺病毒 局灶性脑缺血 模型 动物 hepatocyte growth factor adenoviridae recombinant adenovirus focal cerebral ischemia model,animal
  • 相关文献

参考文献3

二级参考文献17

  • 1Tio R A, Tkebuchava T, Scheuermann T H, et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collareal flow to ischemic myocardium. Hum Gene Ther, 1999, 10(18): 2953~2960 被引量:1
  • 2Patel S R, Lee L Y, Mack C A, et al. Safety of direct myocardial administration of an adenviral vector encoding VEGF121. Hum Gene Ther, 1999, 10: 1331~1348 被引量:1
  • 3Stuart K A, Riordan S M. Hepatocyte growth factor/scattering factor-induced intracellular signalling. Int J Exp Path, 2000, 81: 17~30 被引量:1
  • 4Stella M S, Comoglio P M. Hepatocyte growth factor: a multifunctional growth factor controlling cell scattering. The International Journal of Biochemistry & Cell biology, 1999, 31: 1357~1362 被引量:1
  • 5Vargas G A, Aoki M, Jehle P M. Hepatocyte growth factor in renal failure: Promise and reality. Kidney International, 2000, 57: 1426~1436 被引量:1
  • 6Moroshita R, Hoeflich A, Nakamura S, et al. Gene therapy for cardiovascular disease using hepatocyte growth factor. Ann NY Acad Sci, 2000, 902: 369~376 被引量:1
  • 7Yasuda S, Goto Y, Baba T, et al. Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function. J Am Coll Cardiol, 2000, 36(1): 115~121 被引量:1
  • 8Nakamura T, Mizuno S, Matsumoto K, et al. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest, 2000, 106(12): 1511~1519 被引量:1
  • 9Sambrook J, Friston E F, Manialtis T, et al. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratry Press, 1998. 16 ~ 23, 264 ~ 291 被引量:1
  • 10Graham F L, Prevec L. Methods for construction of adenovirus vectors. Mol Biotechnol, 1995, 3(3): 207~220 被引量:1

共引文献66

同被引文献76

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部